KDIGO Mourns Passing of Tess Harris |
|
With heavy hearts, KDIGO acknowledges the passing of dear friend and longtime volunteer, Tess Harris. In the realm of polycystic kidney disease (PKD) advocacy and research, Tess was an inspiring and admired leader who dedicated her life to advancing PKD care. She was also a catalyst for change, fostering productive communication among clinicians, researchers, patients, and caregivers. Her engaging personality and genuine kindness created a collaborative PKD community that continues to grow and flourish.
Tess lent her expertise and passion to many initiatives. As the CEO of the PKD Charity, Tess championed work aimed at accelerating research, empowering patients, and raising awareness about PKD. Under her leadership, the foundation thrived, becoming a driving force in the PKD community and beyond. As a Work Group member on the forthcoming KDIGO Autosomal Dominant Polycystic Kidney Disease (ADPKD) Guideline, Tess was a highly knowledgeable patient advocate whose insights will help shape the ADPKD guideline and clinical practice. Her work helped lay the foundation for future generations to continue the fight against PKD.
|
|
KDIGO to Mark World Kidney Day 2024 with Release of CKD Guideline |
|
World Kidney Day is on March 14, 2024. This year's theme is "Kidney Health For All: Advancing equitable access to care and optimal medication practice."
KDIGO will honor World Kidney Day by releasing the 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) on March 13. This global guideline will address key issues and topics related to CKD care and provide actionable recommendations, to improve kidney health for people around the world. Mark your calendars for the KDIGO CKD Guideline publication and World Kidney Day 2024. Learn more.
|
|
An Expert Approach to Cardio-Renal Protection in CKD
Free CME Webinar
Monday, March 11 16:30 GMT
This two part program will consider our current guideline-directed approach to chronic kidney disease (CKD) and how SGLT-2 inhibitors can be used to maximal effect. Join us for part one on March 11 for a unique case-based discussion, chaired by Professor James Burton, MD (University of Leicester, United Kingdom) with expert insight from world-renowned faculty, Professor David Wheeler, MD (University College London, United Kingdom), Professor Navdeep Tangri, MD (University of Manitoba, Canada), and Professor Carol Pollock, MD (University of Sydney, Australia).
In this dynamic series, our expert panel will unravel the complexities of CKD care in the context of a real-world patient case. Part two, on April 18, will offer a forensic analysis of current practices, revisiting the patient case in reflection of expected guideline updates. In this part, our panel will provide you with evidence-based strategies for initiating pharmacological therapies that transcend the theoretical and become actionable in everyday practice. Register now.
|
|
e-SPACE Cardio-Renal-Metabolic 2024
Free Virtual Program
Friday, March 22 and Saturday, March 23
KDIGO and Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology are delighted to for this year's e-SPACE Cardio-Renal-Metabolic (CRM) to be held 22–23 March 2024. Last year’s event united over 60 renowned experts worldwide, attracting a live global audience of thousands. You can now watch e-SPACE CRM 2023 on-demand.
Bringing together thought leaders from across the globe, e-SPACE CRM will both optimize geographical reach while delivering both global and regional insight with best-in-class free-to-access virtual education. This thoughtfully curated program will support the exploration of how leading experts, in cardiology, nephrology and diabetology, are treating the interrelated diseases. Through a meticulous selection of sessions and discussions, the programme offers a unique opportunity for participants to directly pose questions to the experts.
Building on the success of e-SPACE CRM 2023, the 2024 edition will once again bring together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, alongside KDIGO's mission to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Underpinned by the combined expertise in educational content and delivery and guided by an esteemed international faculty, e-SPACE CRM 2024 is poised to be the most expansive and captivating edition to date. Register now.
|
|
KDIGO Top 10 Takeaways from the KDIGO 2024 Lupus Nephritis Guideline
The Lupus Nephritis Guideline Top 10 Takeaways for Clinicians are also now available in Russian. KDIGO thanks Elena Zakharova for the translation.
|
|
Separating Fact from Fiction: The Realities of CKD-aP
Free CME Webinar
Available On-Demand in English and French
Chronic kidney disease-associated pruritus, or CKD-aP, is an underreported and underdiagnosed condition, significantly affecting the quality of life of patients with advanced kidney disease undergoing dialysis. Despite its prevalence, there are limited treatment options available for these patients.
This exciting program, which is also available in French, is designed to meet the educational needs of nephrologists, dermatologists, nephrology nurses and dialysis nurses. After participating in this educational activity, participants should be better able to review the pathophysiology of CKD-aP, discuss the symptom burden of CKD-aP on health-related quality of life and patient-reported outcomes, and identify the limitations of current therapies used to treat CKD-aP.
|
|
|
|
|
|
|
